Back to search

Article

Peripheral blood<i>GATA2</i>expression impacts<i>RNF213</i>mutation penetrance and clinical severity in moyamoya disease

2024-06-28

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> The p.R4810K founder mutation in the RNF213 gene confers susceptibility to moyamoya disease (MMD) and non-MMD intracranial artery disease. However, penetrance is incomplete, and the underlying molecular mechanism remains unknown. <h4>Methods and Results</h4> Transcriptome analysis of peripheral blood was conducted with 9 MMD patients and 5 unaffected mutation carriers from 4 f...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b95811d5-b392-5db8-8595-b85b2626c199
DOI
10.1101/2024.06.22.24306750
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Peripheral blood<i>GATA2</i>expression impacts<i>RNF213</i>mutation penetrance and clinical severity in moyamoya diseaseDOI 10.1101/2024.06.22.24306750
Select a neighboring publication to make it the new centre.